This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carlsson, A.
Right arrow Articles by Ivarsson, S.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carlsson, A.
Right arrow Articles by Ivarsson, S.-A.
Related Collections
Right arrow Genetics & Dysmorphology

PEDIATRICS Vol. 101 No. 2 February 1998, pp. 272-275

Prevalence of IgA-Antigliadin Antibodies and IgA-Antiendomysium Antibodies Related to Celiac Disease in Children With Down Syndrome

Received Feb 24, 1997; accepted Jul 16, 1997.

Annelie Carlsson*, Irené Axelsson*, Stefan Borulf*, Anders BredbergDagger , Marianne Forslund*, Bengt Lindberg*, Klas Sjöberg§, and Sten-Anders Ivarsson*

From the Departments of * Pediatrics and Dagger  Medical Microbiology, and the § Department of Medicine, University of Lund, University Hospital, Malmö, Sweden.

Objective.  This study was undertaken to investigate the prevalence of celiac disease in children and adolescents with Down syndrome.

Material and Methods.  Forty-three children and adolescents with Down syndrome were screened for IgA-antigliadin antibodies (AGA) and IgA-antiendomysium antibodies (EMA). Patients found to be either AGA- or EMA-positive were investigated further with intestinal biopsy.

Results.  None of the 43 patients had known celiac disease at entry into the study; 37% (16/43) were found to have AGA levels above normal, and 16% (7/43) to be EMA-positive. Of the 15 patients who underwent biopsy, 8 manifested villous atrophy. Villous atrophy was present in all 7 of the EMA-positive patients, whereas the villi were normal in 7 of the 13 AGA-positive patients who underwent biopsy.

Conclusions.  EMA is a good immunologic marker for use in screening for celiac disease, and screening is justified in patients with Down syndrome.

Key words: Down syndrome, celiac disease, IgA-antigliadin antibodies, IgA-antiendomysium antibodies.




This article has been cited by other articles:


Home page
 PediatricsHome page
N. L. Swigonski, H. L. Kuhlenschmidt, M. J. Bull, M. R. Corkins, and S. M. Downs
Screening for Celiac Disease in Asymptomatic Children With Down Syndrome: Cost-effectiveness of Preventing Lymphoma
Pediatrics, August 1, 2006; 118(2): 594 - 602.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
S Davison
Coeliac disease and liver dysfunction
Arch. Dis. Child., October 1, 2002; 87(4): 293 - 296.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. K. Carlsson, I. E. M. Axelsson, S. K. Borulf, A. C. A. Bredberg, and S.-A. Ivarsson
Serological Screening for Celiac Disease in Healthy 2.5-Year-Old Children in Sweden
Pediatrics, January 1, 2001; 107(1): 42 - 45.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child.Home page

Arch. Dis. Child., November 1, 2000; 83(5): 456 - 456.
[Full Text]

Home page
 Arch. Dis. Child.Home page
R K RUSSELL and P M GILLETT
Coeliac screening just as important!
Arch. Dis. Child., November 1, 2000; 83(5): 456c - 456.
[Full Text]